RYAN SPECIALTY HOLDINGS, INC.·4

May 6, 5:28 PM ET

Hamilton Janice M 4

4 · RYAN SPECIALTY HOLDINGS, INC. · Filed May 6, 2026

Research Summary

AI-generated summary of this filing

Updated

Ryan Specialty (RYAN) CFO Janice Hamilton Receives 33,715-Share Option Grant

What Happened

  • Janice M. Hamilton, Chief Financial Officer of Ryan Specialty Holdings, was awarded a grant of derivative securities on 2026-05-05 equal to 33,715 shares (reported at $0 acquisition price). This was an equity compensation award (stock options/rights), not a cash purchase or sale.

Key Details

  • Transaction date: 2026-05-05; Form 4 filed 2026-05-06 (timely).
  • Amount: 33,715 option-equivalent shares reported as acquired; filing records $0 cash paid at grant.
  • Vesting: Options vest in equal amounts on July 1, 2029, 2030 and 2031 and are exercisable 1-for-1 for Class A common stock (per footnote).
  • Approval: Grant was approved by the compensation and governance committee (noted for compliance with Rule 16(b)(3)).
  • Shares owned after transaction: not disclosed in the supplied filing excerpt.
  • No indication of sale, exercise, or tax-withholding in this filing.

Context

  • This was an option/award grant (derivative); Hamilton did not exercise options or acquire shares for cash at this time. Such grants are a common form of executive compensation and vest over future dates, so they represent potential future share purchases if exercised rather than an immediate market transaction.

Insider Transaction Report

Form 4
Period: 2026-05-05
Hamilton Janice M
Chief Financial Officer
Transactions
  • Award

    Executive Chairman Stock Option

    [F1]
    2026-05-05+33,71533,715 total
    Exercise: $29.66Exp: 2036-05-05Class A Common Stock (33,715 underlying)
Footnotes (1)
  • [F1]The stock options vest in equal amounts on July 1, 2029, 2030 and 2031 and are exercisable on a 1-for-1 basis for shares of Class A common stock, par value $0.001 per share, of the Issuer. Such grant was approved by the compensation and governance committee of the board of the Issuer for the purposes of rule 16(b)(3).
Signature
/s/ Mark S. Katz, as Attorney-in-Fact|2026-05-07

Documents

1 file
  • 4
    wk-form4_1778102880.xmlPrimary

    FORM 4